Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
PLoS One ; 12(3): e0171670, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28278190

RESUMO

BACKGROUND. OBJECTIVES: Behavioral changes in a febrile child are usually considered to stem from the fever. We studied sickness behavior (SB) in terms of its clinical components and its relation to fever. METHODS: This observational, multicenter study included children aged 6 months to 3 years who were either febrile (fever ≥12 hours, ≥ 39°C and ≥38°C at inclusion) or non-febrile and well. The child had to have been awake for the 2 hours preceding the consultation and cared for by the parent who brought him/her to the doctor. SB was evaluated according to 6 parameters over this 2-hour period: time spent playing, distance covered, time spent seeking comfort, time spent whining or crying, time spent in a state of irritation or of anger, most distorted facial expression. Two parameters were assessed for the 24-hour period preceding the consultation: time spent sleeping and appetite. The parent reported the degree of change in these parameters compared with the usual situation, using rating scales. RESULTS: 200 febrile children (most with nonspecific upper respiratory infections) and 200 non-febrile children were included. The mean values of the 8 parameters differed significantly (p<0.001) between the 2 groups and were independent of the height of fever at inclusion in the febrile children. In the study conditions, paracetamol failed to improve SB when the child was still feverish. CONCLUSION: The 8 parameters suggested that SB and fever are two independent manifestations that are activated simultaneously during an infection. This independence is in harmony with recommendations to treat the discomfort of SB and not the fever.


Assuntos
Febre/psicologia , Comportamento de Doença , Infecções Respiratórias/psicologia , Índice de Gravidade de Doença , Anti-Inflamatórios não Esteroides/uso terapêutico , Pré-Escolar , Feminino , Febre/tratamento farmacológico , Febre/etiologia , Humanos , Lactente , Masculino , Infecções Respiratórias/complicações , Infecções Respiratórias/tratamento farmacológico
2.
J Antimicrob Chemother ; 71(10): 2949-56, 2016 10.
Artigo em Inglês | MEDLINE | ID: mdl-27330068

RESUMO

OBJECTIVES: The objective of this study was to evaluate the evolution and risk factors of ESBL-producing Enterobacteriaceae (ESBL-E) carriage in children in the community for a long period distinguishing ST131 and non-ST131 Escherichia coli. PATIENTS AND METHODS: In this prospective study, rectal samples were obtained from children aged 6-24 months by community paediatricians between 2010 and 2015. Demographic characteristics and risk factors for ESBL-E carriage were collected. Distribution of ß-lactamase genes, phylogenetic groups, ST131 and virulence factors of resistant E. coli was determined. RESULTS: We enrolled 1886 children; 144 (7.6%) harboured ESBL-E, and this rate increased from 4.8% to 10.2% between 2010 and 2015. Risk factors for ESBL-E carriage were being cared for at home [adjusted OR (aOR) = 1.8, 95% CI = 1.1-2.9], recent antibiotic use (aOR = 1.5, 95% CI = 1.0-2.1) and travel history (aOR = 1.7, 95% CI = 1.1-2.6). Among patients carrying ESBL, E. coli (98%) and CTX-M type (90%) predominated and PapGII adhesin, characteristic of pyelonephritogenic E. coli strains, was rare (7%). In 2015, E. coli isolates frequently belonged to the phylogenetic group B2 (48%), and 37% were ST131 compared with 5% in 2010. Compared with non-ESBL-producing strains, ST131 carriage was associated with hospitalization in the last 6 months (aOR = 3.5, 95% CI = 1.4-8.8). CONCLUSIONS: Between 2010 and 2015, the carriage of ESBL-E in community children doubled because of the massive expansion of the E. coli ST131 clonal group. The risk for carrying ST131 was associated with previous hospitalization, but not, contrary to the counterpart, antibiotic treatment, daycare attendance or travel history.


Assuntos
Portador Sadio/microbiologia , Infecções por Escherichia coli/epidemiologia , Infecções por Escherichia coli/microbiologia , Escherichia coli/enzimologia , Escherichia coli/genética , Evolução Molecular , beta-Lactamases/biossíntese , Antibacterianos/uso terapêutico , Portador Sadio/epidemiologia , Pré-Escolar , DNA Bacteriano/genética , Eletroforese em Gel de Campo Pulsado , Escherichia coli/isolamento & purificação , Feminino , Genótipo , Humanos , Lactente , Masculino , Filogenia , Prevalência , Estudos Prospectivos , Fatores de Risco , Fatores de Virulência/genética , beta-Lactamases/genética
3.
Pediatr Infect Dis J ; 33(5): 533-6, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24263220

RESUMO

After PCV7 implementation, clinical characteristics were investigated in 832 young children with acute otitis media, carrying a single S. pneumoniae or H. influenzae in their nasopharynx. As compared with H. influenzae, S. pneumoniae-associated acute otitis media was less frequently associated with treatment failure (odds ratio = 0.5; 95% confidence interval: 0.36-0.83) and recurrence (odds ratio = 0.4; 95% confidence interval: 0.22-0.75). Post-PCV7 serotype replacement seemed not to affect the acute otitis media characteristics in these children.


Assuntos
Infecções por Haemophilus/epidemiologia , Infecções por Haemophilus/patologia , Nasofaringe/microbiologia , Otite Média/epidemiologia , Otite Média/patologia , Infecções Pneumocócicas/epidemiologia , Infecções Pneumocócicas/patologia , Portador Sadio/epidemiologia , Portador Sadio/microbiologia , Feminino , Infecções por Haemophilus/microbiologia , Haemophilus influenzae , Vacina Pneumocócica Conjugada Heptavalente , Humanos , Lactente , Masculino , Otite Média/microbiologia , Infecções Pneumocócicas/microbiologia , Vacinas Pneumocócicas/administração & dosagem , Recidiva , Streptococcus pneumoniae , Resultado do Tratamento
4.
BMC Infect Dis ; 12: 52, 2012 Mar 07.
Artigo em Inglês | MEDLINE | ID: mdl-22397629

RESUMO

BACKGROUND: Several studies have investigated the impact of 7-valent pneumococcal conjugate vaccine (PCV7) on pneumococcal (Sp) and staphylococcal (Sa) nasopharyngeal (NP) carriage. Few have investigated the impact on Haemophilus influenzae (Hi) and Moraxella catarrhalis (Mc) carriage. We aimed to compare the NP carriage rates in young children with acute otitis media (AOM) before and after PCV7 implementation in France. METHODS: Prior to PCV7 implementation, we performed 4 successive randomized trials with NP samples. These studies compared several antibiotic regimens for treating AOM in young children (6 to 30 months). After PCV7 implementation, to assess the impact of the vaccination program on NP flora, young children with AOM were enrolled in a prospective surveillance study. In each study, we obtained an NP sample to analyze the carriage rates of Sp, Hi, Mc and Sa and the factors influencing the carriage. Standardized history and physical examination findings were recorded; the methods used for NP swabs (sampling and cultures) were the same in all studies. RESULTS: We enrolled 4,405 children (mean age 13.9 months, median 12.8). Among the 2,598 children enrolled after PCV7 implementation, 98.3% were vaccinated with PCV7. In comparing the pre- and post-PCV7 periods, we found a slight but non-significant decrease in carriage rates of pneumococcus (AOR = 0.85 [0.69;1.05]), H. influenzae (AOR = 0.89 [0.73;1.09]) and S. aureus (AOR = 0.92 [0.70;1.19]). By contrast, the carriage rate of M. catarrhalis increased slightly but not significantly between the 2 periods (AOR = 1.08 [0.95;1.2]). Among Sp carriers, the proportion of PCV7 vaccine types decreased from 66.6% to 10.7% (P < 0.001), penicillin intermediate-resistant strains increased from 30.3% to 43.4% (P < 0.001), and penicillin-resistant strains decreased greatly from 22.8% to 3.8% (P < 0.001). The proportion of Hi ß-lactamase-producing strains decreased from 38.6% to 17.1% (P < 0.001). CONCLUSION: The carriage rates of otopathogen species (Sp, Hi, Mc) and Sa did not significantly change in children with AOM after PCV7 implementation in France. However, we observed significant changes in carriage rates of PCV7 vaccine serotypes and penicillin non-susceptible Sp.


Assuntos
Biota , Portador Sadio/epidemiologia , Portador Sadio/microbiologia , Nasofaringe/microbiologia , Otite Média/microbiologia , Vacinas Pneumocócicas/imunologia , Pré-Escolar , Feminino , França , Haemophilus influenzae/isolamento & purificação , Vacina Pneumocócica Conjugada Heptavalente , Humanos , Lactente , Masculino , Moraxella catarrhalis/isolamento & purificação , Vacinas Pneumocócicas/administração & dosagem , Prevalência , Estudos Prospectivos , Ensaios Clínicos Controlados Aleatórios como Assunto , Staphylococcus aureus/isolamento & purificação , Streptococcus pneumoniae/isolamento & purificação
5.
BMC Infect Dis ; 11: 95, 2011 Apr 18.
Artigo em Inglês | MEDLINE | ID: mdl-21501471

RESUMO

BACKGROUND: After the implementation of 7-valent pneumococcal conjugate vaccine (PCV7), in several countries, serotype 19A is now the serotype most frequently involved in pneumococcal diseases and carriage. To determine factors potentially related to 19A nasopharyngeal (NP) carriage we analyzed data from an ongoing prospective French national surveillance study of pneumococcal NP carriage in young children. METHODS: NP swabs were obtained from children aged 6 to 24 months, either during routine check-ups with normal findings, or when they presented with acute otitis media (AOM). The swabs were sent for analysis to the French National Reference Centre for Pneumococci. Factors influencing pneumococcal carriage and carriage of penicillin non-susceptible (PNSP), 19A and PNS-19A were investigated by multivariate logistic regression. RESULTS: From 2006 to 2009, 66 practitioners enrolled 3507 children (mean age 13.6 months), of whom, 98.3% of children had been vaccinated with PCV7 and 33.4% of children attended daycare centres (DCC). Serotype 19A was found in 10.4% of the overall population, 20.5% of S. pneumoniae carriers (n = 1780) and 40.8% of PNSP carriers (n = 799). Among 19A strains, 10.7% were penicillin-susceptible, 80% intermediate and 9.3% fully resistant. Logistic regression analysis showed that the main factors associated with PNSP carriage were AOM (OR = 3.09, 95% CI [2.39;3.98]), DCC (OR = 1.70, 95% CI [1.42;2.03]), and recent antibiotic use (OR = 1.24, 95% CI [1.05;1.47]. The main factors predictive of 19A carriage were recent antibiotic use (OR = 1.81, 95% CI [1.42;2.30]), AOM (OR = 1.67, 95% CI [1.11;2.49]), DCC (OR = 1.56, 95% CI [1.21;2.2] and young age, <12 months (OR = 1.51, 95% CI [1.16;1.97]). CONCLUSION: In a population of children aged from 6 to 24 months with a high rate of PCV7 vaccination coverage, we found that antibiotic exposure, DCC attendance and AOM were linked to 19A carriage.


Assuntos
Portador Sadio/microbiologia , Infecções Pneumocócicas/microbiologia , Vacinas Pneumocócicas/imunologia , Streptococcus pneumoniae/imunologia , Portador Sadio/epidemiologia , Estudos de Casos e Controles , Farmacorresistência Bacteriana , Feminino , França/epidemiologia , Vacina Pneumocócica Conjugada Heptavalente , Humanos , Lactente , Modelos Logísticos , Masculino , Análise Multivariada , Cavidade Nasal/microbiologia , Otite Média/epidemiologia , Otite Média/microbiologia , Penicilinas/farmacologia , Infecções Pneumocócicas/epidemiologia , Infecções Pneumocócicas/prevenção & controle , Fatores de Risco , Sorotipagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...